Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest & Investment Income (2023 - 2025)

Lisata Therapeutics (LSTA) has disclosed Interest & Investment Income for 3 consecutive years, with $183000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 59.42% year-over-year to $183000.0, compared with a TTM value of $1.0 million through Sep 2025, down 53.95%, and an annual FY2024 reading of $1.9 million, down 30.87% over the prior year.
  • Interest & Investment Income was $183000.0 for Q3 2025 at Lisata Therapeutics, down from $216000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $714000.0 in Q3 2023 and bottomed at $183000.0 in Q3 2025.
  • Average Interest & Investment Income over 3 years is $479181.8, with a median of $493000.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income fell 12.09% in 2024, then crashed 59.42% in 2025.
  • Year by year, Interest & Investment Income stood at $671000.0 in 2023, then crashed by 47.84% to $350000.0 in 2024, then tumbled by 47.71% to $183000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for LSTA at $183000.0 in Q3 2025, $216000.0 in Q2 2025, and $266000.0 in Q1 2025.